Investment of CHF 4 Million
March 3rd, 2013 - MyoPowers closes an Investment of CHF 4 Million with a Swiss private investor.
LAUSANNE, SWITZERLAND - April 3, 2013: MyoPowers Medical Technologies SA, a Swiss medical device startup developing artificial muscle technologies to treat incontinences, announced today that it has closed a CHF 4 million investment round with a Swiss private investor.
According to the Chairman of the Board, Ivan Csendes, “The addition of another private investor allows MyoPowers an additional degree of flexibility to reach its ambitious target to become a major player in the field of incontinences .”
“This investment which attracted a new high calibre investor is additional testimony to people’s confidence in our technology and team,” said the CEO, Martin Horst. “These funds will help us bring our technology to the market in Europe soon. We are very grateful to our investors, board of directors and advisory board for their ongoing support.”
MyoPowers Medical Technologies SA was founded by Dr Piergiorgio Tozzi, MD, of the University Hospital of Lausanne (CHUV), Switzerland and Professor Daniel Hayoz of the Cantonal Hospital of Fribourg and the CHUV. Capitalizing on their long experience in surgery, vascular medicine, and innovative device development, they have developed a unique artificial muscle technology. MyoPowers’ initial focus is on the application of this proprietary technology in the development of artificial muscles for the treatment of incontinences. For further information, please visit www.myopowers.com.